Santa Cruz, CA, United States of America

Richard Theolis

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 15.6

ph-index = 3

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Journey of Richard Theolis

Introduction

Richard Theolis, an accomplished inventor based in Santa Cruz, California, has made significant contributions to the field of biotechnology with a total of 12 patents to his name. His work primarily revolves around innovative antibody technologies that have the potential to revolutionize therapeutic approaches in cancer treatment and immunology.

Latest Patents

Among his latest inventions are the "Anti-PVRIG antibodies and methods of use," which focuses on the development of anti-PVRIG antibodies and their applications in various medical contexts. Additionally, he has been involved in creating "Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof," providing valuable tools for advancing cancer immunotherapy through a combination of antibody treatments.

Career Highlights

Richard Theolis has worked with several prominent organizations, substantially contributing to the scientific community. He has been associated with Compugen Ltd. Corporation, where he advanced research into innovative therapeutic solutions. He also played a key role at Medarex Inc., a company known for its pioneering work in monoclonal antibody development.

Collaborations

Throughout his career, Richard has collaborated with notable figures in the field, including Mark Leslie White and Sandeep Kumar. These collaborations have further enriched his experience and have facilitated the development of groundbreaking inventions.

Conclusion

Richard Theolis continues to be a leading figure in the biotechnology domain, with his patents paving the way for future advancements in antibody therapies. His dedication to innovation exemplifies the crucial role inventors play in shaping the future of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…